ROLE OF HEAVY/LIGHT CHAIN ASSAY, ALONE AND IN COMBINATION WITH FREE LIGHT CHAIN ASSAY AND MINIMAL RESIDUAL DISEASE, IN MYELOMA PATIENTS WHO ACHIEVE COMPLETE RESPONSE AFTER FIRST LINE TREATMENTS
EHA Library, Pellegrino Musto,
102995
OUTCOME OF FRONTLINE TREATMENT WITH GENERIC IMATINIB ACCORDING TO ELN 2009 BASED NATIONAL GUIDELINES. EXPERIENCE FROM UNIVERSITY CLINIC OF HEMATOLOGY, CLINICAL CENTER OF SERBIA, BELGRADE
EHA Library, Andrija Bogdanovic,
103019